HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

TiterMax

a non-ionic block polymer surfactant; belongs to a group of adjuvants made up of oil-in-water emulsions and pluronics

Also Known As:

Titer Max

Networked: 6 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Barin, Jobert G: 1 article (01/2017)
2.	Fontes, Jillian A: 1 article (01/2017)
3.	Rose, Noel R: 1 article (01/2017)
4.	Schaub, Julie: 1 article (01/2017)
5.	Stickel, Natalie: 1 article (01/2017)
6.	Talor, Monica V: 1 article (01/2017)
7.	Čiháková, Daniela: 1 article (01/2017)
8.	Segura, Mariela: 1 article (04/2006)
9.	Stevenson, Mary M: 1 article (04/2006)
10.	Su, Zhong: 1 article (04/2006)

Related Diseases

1.	Malaria 04/01/2006 - "chabaudi AS antigen in TiterMax adjuvant developed strong protection against malaria challenge. " 08/01/1997 - "Mice immunized with vaccinia virus expressing full-length PfSSP2 protein produced antibodies to (DRYIPYSP)3, and humans living in malaria-endemic areas (Indonesia and Kenya), who have lifelong exposure and partial clinical immunity to malaria, had antibodies to both (DRYIPYSP)3 and (CHPSDGKCN)2. Mice immunized with multiple antigen peptides MAP4 (DRYIPYSP)3P2P30 and MAP4 (CHPSDGKCN)3P2P30 in TiterMax developed antibodies to sporozoites that partially inhibited sporozoite invasion of human hepatoma cells (39 to 71% at a serum dilution of 1:50 in three different experiments). "
2.	Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis) 06/01/1993 - "C57BL/6 mice were inoculated with Torpedo acetylcholine receptors (T-AChR) emulsified in Titermax (TM), an adjuvant containing nonionic block copolymer and no microbial products, and evaluated for experimental autoimmune myasthenia gravis (EAMG) susceptibility. "
3.	Myocarditis (Carditis) 01/01/2017 - "We compared the effectiveness of CFA with Incomplete Freund's Adjuvant (IFA) or TiterMax Gold Adjuvant (TMax) in experimental autoimmune myocarditis (EAM) in male mice. "
4.	Infections 04/14/2000 - "The experimental groups were immunized intradermally with rSJPM and alum or TiterMax and were partially protected against the challenge infection (32-35% reduction)."
5.	Hepatocellular Carcinoma (Hepatoma) 08/01/1997 - "Mice immunized with vaccinia virus expressing full-length PfSSP2 protein produced antibodies to (DRYIPYSP)3, and humans living in malaria-endemic areas (Indonesia and Kenya), who have lifelong exposure and partial clinical immunity to malaria, had antibodies to both (DRYIPYSP)3 and (CHPSDGKCN)2. Mice immunized with multiple antigen peptides MAP4 (DRYIPYSP)3P2P30 and MAP4 (CHPSDGKCN)3P2P30 in TiterMax developed antibodies to sporozoites that partially inhibited sporozoite invasion of human hepatoma cells (39 to 71% at a serum dilution of 1:50 in three different experiments). "

Related Drugs and Biologics

1.	Antigens
2.	Cholinergic Receptors
3.	Proteins (Proteins, Gene)
4.	Peptides (Polypeptides)
5.	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)
6.	Gold
7.	Antibodies
8.	incomplete Freund's adjuvant
9.	aluminum sulfate (alum)